John Glenn

John Glenn (finance chief) discloses dealings in 2 companies, chiefly Iradimed Corp and ChronoScale Holdings Corp. In total, 12 filings cover trades dated from 17 February 2022 to 20 June 2026.

On the market, this insider has only sold: 4 sales, €2.1M in total. Other entries cover 3 share grants and 5 option exercises.

Most recently, on 23 June 2026, the filings show an option exercise in Iradimed Corp. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.